artesunic acid has been researched along with Cytomegalovirus Infections in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Bhat, V; Biswas, S; Bonda, A; Chichra, A; Gokarn, A; Jindal, N; Khattry, N; Kumar, S; Mirgh, S; Nayak, L; Prayag, P; Punatar, S; Saroha, M; Shenoy, R; Toshniwal, A; Tripathi, R | 1 |
| Alain, S; Andouard, D; Chianea, T; El Hamel, C; Hantz, S; Jacquet, C; Marschall, M; Tsogoeva, SB | 1 |
| Bertzbach, LD; Fröhlich, T; Hahn, F; Herrmann, L; Kaufer, BB; Marschall, M; Müller, R; Tannig, P; Tsogoeva, SB; Wangen, C; Wild, M | 1 |
| Ackermann, L; Grau, B; Hahn, F; Herrmann, L; Lorion, MM; Marschall, M; Niesar, A; Schütz, M; Tsogoeva, SB; Wild, M | 1 |
| Arav-Boger, R; Ghosh, AK; Kapoor, A; Lee, H; Mazzone, J; Mukhopadhyay, R; Posner, GH; Roy, S; Zhu, F | 1 |
| Bertzbach, LD; Frank, T; Fröhlich, T; Hahn, F; Kaufer, BB; Kohrt, S; Marschall, M; Stamminger, T; Tsogoeva, SB | 1 |
| Bunts, L; Casper, C; Dorsey, G; Gantt, S; Huang, ML; Magaret, A; Rosenthal, PJ; Selke, S; Wald, A | 1 |
| Alain, S; Brion, JP; Epaulard, O; Germi, R; Lupo, J; Malvezzi, P; Mariette, C; Morand, P; Saint Raymond, C; Thiebaut, A | 1 |
| Alain, S; Andouard, D; Aubard, Y; Calliste, CA; Cotin, S; Esclaire, F; Hantz, S; Labrousse, F; Morère, L; Ploy, MC; Rawlinson, WD; Saade, F | 1 |
| Boivin, G; Drouot, E; Piret, J | 1 |
| John, GT; Lau, PK; Ratanjee, SK; Woods, ML | 1 |
| Caplan, O; Chou, S; Efferth, T; Marschall, M; Nagler, A; Neumann, AU; Resnick, IB; Rose, J; Shimoni, A; Stamminger, T; Wolf, DG | 1 |
| Auerochs, S; Bruggeman, CA; Efferth, T; Kalmer, M; Kaptein, SJ; Leis, M; Marschall, M; Rechter, S; Stamminger, T; Vink, C | 1 |
| Caplan, O; Chou, S; Efferth, T; Lurain, NS; Marschall, M; Neumann, AU; Resnick, IB; Saleh, N; Shapira, MY; Stamminger, T; Wolf, DG | 1 |
1 trial(s) available for artesunic acid and Cytomegalovirus Infections
| Article | Year |
|---|---|
An artesunate-containing antimalarial treatment regimen did not suppress cytomegalovirus viremia.
Topics: Adolescent; Antimalarials; Antiviral Agents; Artemisinins; Artesunate; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Real-Time Polymerase Chain Reaction; Treatment Outcome; Uganda; Viremia | 2013 |
13 other study(ies) available for artesunic acid and Cytomegalovirus Infections
| Article | Year |
|---|---|
Efficacy of artesunate for treatment of cytomegalovirus reactivation post allogeneic haematopoietic stem cell transplants.
Topics: Artesunate; Cytomegalovirus; Cytomegalovirus Infections; Hematopoietic Stem Cell Transplantation; Humans; Virus Activation | 2023 |
A highly potent trimeric derivative of artesunate shows promising treatment profiles in experimental models for congenital HCMV infection in vitro and ex vivo.
Topics: Antiviral Agents; Artesunate; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Epithelial Cells; Female; Fibroblasts; Humans; Lung; Organ Culture Techniques; Placenta; Pregnancy; Virus Replication | 2020 |
The trimeric artesunate derivative TF27 exerts strong anti-cytomegaloviral efficacy: Focus on prophylactic efficacy and oral treatment of immunocompetent mice.
Topics: Administration, Oral; Animals; Antiviral Agents; Artesunate; Cells, Cultured; Chick Embryo; Cytomegalovirus; Cytomegalovirus Infections; Drugs, Investigational; Humans; Marek Disease; Mice; Virus Replication | 2020 |
The Artemisinin-Derived Autofluorescent Compound BG95 Exerts Strong Anticytomegaloviral Activity Based on a Mitochondrial Targeting Mechanism.
Topics: Antiviral Agents; Artemisinins; Artesunate; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Fluorescent Dyes; Humans; Mitochondria; Viral Proteins; Virus Replication | 2020 |
Artemisinins target the intermediate filament protein vimentin for human cytomegalovirus inhibition.
Topics: Antiviral Agents; Artemisinins; Artesunate; Binding Sites; Calpain; Cell Cycle; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Drug Repositioning; Humans; Mass Spectrometry; Phosphorylation; Proteasome Endopeptidase Complex; Vimentin; Virus Replication; Withanolides | 2020 |
Artesunate-derived monomeric, dimeric and trimeric experimental drugs - Their unique mechanistic basis and pronounced antiherpesviral activity.
Topics: Antiviral Agents; Artesunate; Cytomegalovirus; Cytomegalovirus Infections; Dimerization; Drugs, Investigational; Humans; Microbial Sensitivity Tests; NF-kappa B; Viral Proteins; Virus Replication | 2018 |
Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus.
Topics: Antiviral Agents; Artemisinins; Artesunate; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Organ Transplantation; Transplantation; Treatment Outcome; Viral Load | 2014 |
Ex vivo model of congenital cytomegalovirus infection and new combination therapies.
Topics: Adult; Antiviral Agents; Artemisinins; Artesunate; Benzimidazoles; Cytomegalovirus Infections; Female; Flavanones; Humans; Pregnancy; Pregnancy Complications, Infectious; Ribonucleosides; Trophoblasts | 2015 |
Artesunate demonstrates in vitro synergism with several antiviral agents against human cytomegalovirus.
Topics: Antiviral Agents; Artemisinins; Artesunate; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Synergism; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Viral Proteins; Virus Replication | 2016 |
Artesunate is ineffective in controlling valganciclovir-resistant cytomegalovirus infection.
Topics: Antiviral Agents; Artemisinins; Artesunate; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Humans; Treatment Failure; Valganciclovir | 2011 |
Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation.
Topics: Adult; Aged; Antiviral Agents; Artemisinins; Artesunate; Child; Cytomegalovirus; Cytomegalovirus Infections; Female; Hematopoietic Stem Cell Transplantation; Humans; Kinetics; Male; Middle Aged; Viral Load | 2011 |
The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.
Topics: Animals; Antimalarials; Antiviral Agents; Artemisinins; Artesunate; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Ferrous Compounds; Fibroblasts; Herpesviridae Infections; Humans; Immunocompromised Host; Male; Muromegalovirus; Rats; Rats, Inbred Lew; Sesquiterpenes; Specific Pathogen-Free Organisms; Transferrin; Virus Replication | 2006 |
Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation.
Topics: Antiviral Agents; Artemisinins; Artesunate; Child; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Foscarnet; Hematopoietic Stem Cell Transplantation; Humans; Male; Treatment Outcome | 2008 |